Pamela Marrone - Jun 9, 2022 Form 4 Insider Report for MARRONE BIO INNOVATIONS INC (MBII)

Role
Director
Signature
/s/ Linda V. Moore, as attorney-in-fact
Stock symbol
MBII
Transactions as of
Jun 9, 2022
Transactions value $
-$24,121
Form type
4
Date filed
6/13/2022, 05:20 PM
Previous filing
May 25, 2022
Next filing
Jul 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBII Common Stock Sale -$24.1K -20.5K -0.93% $1.18 2.18M Jun 9, 2022 Direct F1, F2
holding MBII Common Stock 6.44K Jun 9, 2022 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.15 to $1.21, inclusive. The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F3 Ownership is held by Florence H. Marrone TOD Pamela G. Marrone.